The S&P/ASX 200 Index faced a challenging session on Monday, with the benchmark index down 0.58% to 7,925.20 points in afternoon trade. Despite the broader market downturn, some ASX shares managed to rise significantly. Here are three standout performers and the reasons behind their gains:
29Metals Ltd (ASX: 29M)
The share price of 29Metals Ltd surged over 5.41% to 39 cents. Investors reacted positively to the release of promising drilling results from the Capricorn Copper project. The three-hole drill program confirmed the continuity and orientation of a new mineralized zone east of the Mammoth orebody. CEO James Palmer highlighted the potential value to be unlocked at Capricorn Copper and the prospectivity of 29Metals' extensive Mount Isa inlier position, which spans approximately 1,900 square kilometers.
Immutep Ltd (ASX: IMM)
Shares of Immutep Ltd climbed over 1.69% to 30 cents following an announcement from the clinical-stage biotechnology company. Immutep received positive feedback from the US Food and Drug Administration (FDA) regarding its planned TACTI-004 Phase III trial. This trial will evaluate eftilagimod alfa (efti) in combination with Keytruda (Merck & Co's anti-PD-1 therapy) and histology-based platinum doublet chemotherapy for the treatment of first-line metastatic non-small cell lung cancer, regardless of PD-L1 expression. Management described this feedback as a crucial milestone in the late-stage development process for efti.
Insignia Financial Ltd (ASX: IFL)
Insignia Financial Ltd saw its share price rise nearly 5.25% to AU$2.50 apiece. The catalyst for this gain was the release of a positive quarterly update. Insignia reported a return to positive net inflows during the fourth quarter, with total net inflows reaching AU$189 million. This was supported by improved platform flows following the successful migration of MLC Wrap to Expand and continued momentum in the Workplace segment.